Prevention

Papillomavirus: the recommended vaccination up to 26 years for all men and women

Publié le 16 mai 2025 - Mise à jour le 11 septembre 2025 - Directorate of Legal and Administrative Information (Prime Minister)

The High Health Authority has issued a recommendation calling for a catch-up vaccination against the papillomavirus for women and men up to 26 years of age.

On 13 May 2025, the French High Health Authority published a recommendation calling for vaccination catch-up against human papillomavirus (HPV) infections for women and men, up to the age of 26.

The goal is to increase immunization coverage and reduce inequalities related to gender and sexual orientation.

At the same time, the HAS reiterated that the priority remains the vaccination of the main target population, namely adolescents aged 11 to 14 years and over, girls and boys.

The catch-up vaccination, with Gardasil 9 vaccine, is currently being managed:

  • for men and women up to 19 years of age;
  • and up to 26 years for men who have sex with men.

Vaccination schedule according to the situation

  • The human papillomavirus vaccination regimen consists of 2 doses spaced from 5 months to 13 months, for girls and boys aged 11 to 14 years.
  • In catch-up, from 15 to 19 years of age, the vaccination schedule is 3 doses according to a schedule 0, 2 and 6 months.
  • Up to the age of 26 years, for men who have sex with men, the vaccination schedule is 3 doses according to schedule 0, 2 and 6 months.

FYI  

The vaccine against HPV infections is 65% covered by the Health Insurance (the remaining amount is usually reimbursed by complementary health insurance). Since September 2023, vaccination has also been offered free of charge to middle school students in class 5e.

Please note

The HAS reminds that protection is “optimal” when the vaccine is administered early and that it should not wait until adulthood to achieve it. It states that “three-quarters of young adults up to 26 years of age have not yet been exposed to HPM infections but are at high risk of acquiring and transmitting them.”

Agenda